ナノ毒性・安全性の世界市場

世界のナノ毒性・安全性市場は6,240万米ドルと分析され、2027年には1億5,160万米ドルに達すると予測され、2022年から2027年の間に16.61%のCAGRで成長する見込みです。

技術別には、2021年には走査型電子顕微鏡のセグメントが最大の市場シェアを占め、4,368万米ドルを稼ぎ出しました。

プロセス別では、物理化学的プロセスのセグメントが2021年に、形態学的プロセスよりもわずかに大きな市場シェアを達成しました。

毒性試験別では、2021年に細胞培養 (生体外) セグメントが市場シェアを独占しました。

ナノ粒子別では、2021年の市場シェアの大半は、二酸化チタンナノ粒子セグメントによるものです。ルチル、アナターゼ、ブルッカイト、二酸化チタンという4つの異なる結晶構造によって、様々な種類の酸化チタンベースのナノ粒子を区別することができ、ルチルとアナターゼは消費財で最も頻繁に使用されています。

毒性別では、ナノ毒性と安全性市場は、用量依存毒性のセグメントが2021年に最も収益を上げました。

用途別では医薬品セグメントが、ドラッグデリバリー、がんや動脈硬化などの疾患のイメージングと診断、聴覚・視覚障害などにおけるナノテクノロジーの活用により、予測期間中に優位性を維持し、安定的に成長すると分析されています。

地域別では、北米地域は2021年に圧倒的な市場シェアを占めています。米国は、ライフサイエンス、農業、産業エネルギー、その他の分野における様々な研究開発活動のためのナノ毒性試験装置のニーズの高まりと、この地域における主要企業の強力な存在感により、市場に最も収益貢献しています。

目次

第1章 ナノ毒性・安全性市場：概要

第2章 ナノ毒性・安全性市場：エグゼクティブサマリー

第3章 ナノ毒性・安全性市場：情勢

• 市場シェア分析：主要企業
• 製品の相互比較：主要企業
• 財務分析：上位5社
• 特許分析：主要企業
• 価格分析

第4章 ナノ毒性・安全性市場の影響要因

• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析
  • サプライヤーの交渉力
  • 顧客の交渉力
  • 新規参入企業の脅威
  • 既存企業間の競合関係
  • 代替製品の脅威

第5章 ナノ毒性・安全性市場：戦略分析

• バリューチェーン分析
• 市場機会の分析
• 市場のライフサイクル
• サプライヤー/流通業者の分析

第6章 ナノ毒性・安全性市場：技術別 (市場規模 (単位：10億米ドル))

• 走査型電子顕微鏡 (SEM)
• 透過型電子顕微鏡
• その他 (X線回折、熱分析)

第7章 ナノ毒性・安全性市場：生物系別 (市場規模 (単位：10億米ドル))

• 細胞
• 組織
• 生物

第8章 ナノ毒性・安全性市場：プロセス別 (市場規模 (単位：10億米ドル))

• 形態学的プロセス
• 物理化学的プロセス

第9章 ナノ毒性・安全性市場：毒性試験別 (市場規模 (単位：10億米ドル))

• 細胞培養 (生体外)
  • 2Dモデル
  • 3Dモデル
• 生物 (生体内)
  • 水生生物モデル
  • 小型げっ歯類 (哺乳類モデル)

第10章 ナノ毒性・安全性市場：ナノ粒子別 (市場規模 (単位：10億米ドル))

• 二酸化チタンナノ粒子
• 銀ナノ粒子
• その他

第11章 ナノ毒性・安全性市場：毒性別 (市場規模 (単位：10億米ドル))

• サイズ依存毒性
• 表面依存毒性
• 形状依存毒性
• 凝集/凝集依存毒性
• 用量依存毒性

第12章 ナノ毒性・安全性市場：用途別 (市場規模 (単位：10億米ドル))

• エネルギー
• 材料・健康
• 医療システム
• 農業
• 医薬品
• 化粧品
• その他 (工学・食品・その他)

第13章 ナノ毒性・安全性市場：地域別 (市場規模 (単位：10億米ドル))

• 北米
  • 米国
  • カナダ
  • メキシコ
• 南米
  • ブラジル
  • アルゼンチン
  • コロンビア
  • 他の南米諸国
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • フランス
  • スペイン
  • 他の欧州諸国
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア・ニュージーランド
  • 他のアジア太平洋諸国

第14章 ナノ毒性・安全性市場：エントロピー

• 新製品の発売
• 企業合併・買収 (M&A)、事業協力／提携、合弁事業

第15章 ナノ毒性・安全性市場：企業分析

• 市場シェア、企業収益、製品、企業合併・買収 (M&A)、動向
• 分析対象企業 (全10社)

Nano Toxicity and Safety refers to the potential adverse health effects related to engineered nanomaterial exposure and different techniques, tools, and approaches related to the safety of nanotechnology. The nanoparticles' potential for danger is evident due to the high surface area to volume ratio, which can make them highly reactive or catalytic. In addition, they can pass through cell membranes in organisms and may interact with biological systems. The global Nano Toxicity and Safety Market is analyzed to be $62.4 million and is projected to reach $151.6 million in 2027, growing with a CAGR of 16.61 % during 2022-2027. The Nano Toxicity and Safety market is segmented by technique, by process, by toxicity test, by nano particles, by toxicity, and by application in this report. The market is also segmented by geography, which include North America, South America, Europe, and Asia-Pacific.

Nano Toxicity and Safety Market Segment Analysis - By Technique

Nano Toxicity and Safety Market is segmented by technique such as Scanning Electron Microscopy, Transmission Electron Microscopy, and Others (X-ray Diffraction, Thermal Analysis). In 2021, the Scanning Electron Microscopy segment held the greatest market share, generating $43.68 million. Depending on the size and substance used to create nanomaterialss, scanning electron microscopy and transmission electron microscopy are two microscopic methods that characterize morphology. Studies using scanning electron microscopy (SEM) and transmission electron microscopy (TEM) have been carried out to learn more about the morphology, structure, and size of IO-NPs.

Nano Toxicity and Safety Market Segment Analysis - By Process

In terms of process, the Physicochemical Process segment achieved slightly bigger market share of the Nano Toxicity and Safety Market in 2021 than Morphological Process. Nanotoxicology is based on a variety of factors, including size, surface area, morphology, composition, surface chemistry, aggregation/agglomeration phenomena, etc. The interaction of Nanomaterials with biological cells is greatly impacted by their morphological and physicochemical characteristics, which may also affect their toxicity.

Nano Toxicity and Safety Market Segment Analysis - By Toxicity Test

In terms of toxicity test, the Cell Cultures (In Vitro) segment dominated the market share in 2021. The Cell Cultures (In Vitro) segment can be subcategorized into 2D models and 3D models. The most popular technique for determining NM toxicity on a 2D platform involves exposing adherent cells to an NM dispersion where the NMs are dispersed in the media.

Nano Toxicity and Safety Market Segment Analysis - By Nanoparticle

By nanoparticle, the majority of market share in 2021 was from the Titanium Dioxide Nanoparticles segment. Materials use titanium dioxide (TiO2) in a variety of ways such as paper, plastic, ceramics, rubber, printer ink, floor coverings, catalysts, fabrics and textiles, cosmetics, food colors, medicines, paints, coatings, and electronic components. Four different crystalline structures-rutile, anatase, brookite, or titanium dioxide-can be used to distinguish the various types of TiO2-based NMs, with rutile and anatase being the most frequently used in consumer goods.

Nano Toxicity and Safety Market Segment Analysis - By Toxicity

By toxicity, Nano Toxicity and Safety Market is segmented into Size-dependent Toxicity, Surface-dependent Toxicity, Shape-dependent Toxicity, Aggregation or agglomeration-dependent Toxicity and Dose-dependent Toxicity. As one of the critical factors affecting toxicity, the Dose-dependent Toxicity segment generated the most revenue in 2021 Nano Toxicity and Safety market. To determine the minimum dose of NPs which is induces toxicity, dose is very important.

Nano Toxicity and Safety Market Segment Analysis - By Application

Nano Toxicity and Safety Market is segmented by its various application such as Energy, Materials and Health, Medical Systems, Agriculture, Pharmaceutical, Cosmetic, and Others (Engineering, Food and Others). The Pharmaceutical segment is analyzed to hold the dominance and to grow steadily during the forecast period owing to the utilization of nanotechnology in drug delivery, imaging & diagnosis of diseases such as cancer and atherosclerosis, as well as hearing & vision disorders. Thus, the importance of nanomaterial toxicity testing is more highlighted.

Nano Toxicity and Safety Market Segment Analysis - By Geography/Country

The report comprises of the region wise study of the global market including North America, South America, Europe, and Asia-Pacific. Among them, North America region accounted for the dominant market share in 2021. The United States contributes to the most revenue to the market with growing need for nano-toxicity testing devices for various research and development activities in the sectors of Life Science, Agriculture, Industrial Energy, and others as well as the strong presence of key players in this region.

Nano Toxicity and Safety Market- Drivers

One of the primary factors driving the growth in global Nano Toxicity and Safety market is emerging technological advancements in nanotechnology and nanotech devices. Some of advanced nanotechnologies are nano-identification, nano-impact, nano-scratch, and nano-tribological, and they are now used in many testing procedures to better understand materials at the nanoscale. Based on the advanced nanotechnologies, increase in adoption of Nano-toxicology testing in various end-use industries such as the energy, healthcare, cosmetic industry, and others is set to propel the market growth.

Nano Toxicity and Safety - Competitive Landscape

Major companies in the global Nano Toxicity and Safety Market profiled in this report include Horiba, CytoViva, Schaefer-Tec AG, Thermo Fisher Scientific, Carl Zeiss NTS Ltd., Hitachi High-Technologies Corporation, SGS SA, Eurofins Scientific, Charles River Laboratories International Inc., Enviroscience Inc. Technology launches, acquisitions, partnerships and R&D activities are key strategies adopted by the key players in the Nano Toxicity and Safety market.

Nano Toxicity and Safety - Recent Developments

In May 2022, HORIBA UK announces that it has joined the lifETIME Centre for Doctoral Training (CDT) as an Industry Partner. This partnership aims to provide a new generation of scientists with skills and approaches to reduce and replace the need for animal testing, so transforming drug discovery, toxicology screening and regenerative medicine.

In August 2021, Eurofins Discovery, a leading provider of products and services to the drug discovery industry and a Eurofins Scientific company, announced a new commercial collaboration with Fusion Antibodies plc, a specialist in the pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications.

In November 2020, Carl Zeiss NTS Ltd presented a new generation of its field emission scanning electron microscope (FESEM) family ZEISS GeminiSEM. The new models ZEISS GeminiSEM 360, 460 and 560 are tailored for sub-nanometer imaging and effortless analytics. Users benefit from innovations in the electron optics and a new chamber design offering better image quality, usability and flexibility. ZEISS GeminiSEM 560 now being introduced brings the ZEISS Gemini 3 column to the market for the first time.

Nano Toxicity and Safety - Report Scope and Coverage

The base year of the study is 2021, with forecast done up to 2027. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Nano Toxicity and Safety market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, and Nano Toxicity and Safety manufacturing method analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the key global Nano Toxicity and Safety Market players, to define, describe and analyze the sales value, market share, SWOT analysis and development plans in upcoming years.

By Technique: Scanning Electron Microscopy, Transmission Electron Microscopy, Others (X-ray Diffraction, Thermal Analysis)

By Process: Morphological Process, Physicochemical Process

By Toxicity Tests: Cell Cultures (In Vitro) (2D Models & 3D Models), Living Organisms (In Vivo) (Aquatic Models, Small Rodents)

By Nanoparticles: Titanium Dioxide Nanoparticles, Silver Nanoparticles, Others

By Toxicity: Size-dependent Toxicity, Surface-dependent Toxicity, Shape-dependent Toxicity, Aggregation or agglomeration-dependent Toxicity, Dose-dependent Toxicity

By Application: Energy, Materials and Health, Medical Systems, Agriculture, Pharmaceutical, Cosmetic, Others (Engineering, Food and Others)

By Region: North America, South America, Europe, Asia-Pacific

Table of Contents

1. Nano Toxicity and Safety Market- Market Overview

• 1.1 Definitions and Scope

2. Nano Toxicity and Safety Market- Executive Summary

• 2.1 Market Revenue, Market Size and Key Trends by Company

3. Nano Toxicity and Safety Market- Landscape

• 3.1 Market Share Analysis- Top Companies
• 3.2 Product Benchmarking- Top Companies
• 3.3 Top 5 Financials Analysis
• 3.4 Patent Analysis- Top Companies
• 3.5 Pricing Analysis

4. Nano Toxicity and Safety Market- Market Forces

• 4.1 Market Drivers
• 4.2 Market Constraints
• 4.3 Market Opportunities
• 4.4 Porters five force model
  • 4.4.1 Bargaining power of suppliers
  • 4.4.2 Bargaining powers of customers
  • 4.4.3 Threat of new entrants
  • 4.4.4 Rivalry among existing players
  • 4.4.5 Threat of substitutes

5. Nano Toxicity and Safety Market -Strategic analysis

• 5.1 Value chain analysis
• 5.2 Opportunities analysis
• 5.3 Market life cycle
• 5.4 Suppliers and distributors Analysis

6. Nano Toxicity and Safety Market- By Technique (Market Size -$Billion)

• 6.1 Scanning Electron Microscopy
• 6.2 Transmission Electron Microscopy
• 6.3 Others (X-ray Diffraction, Thermal Analysis)

7. Nano Toxicity and Safety Market- By Biological Systems (Market Size -$Billion)

• 7.1 Cells
• 7.2 Tissues
• 7.3 Living Organisms

8. Nano Toxicity and Safety Market- By Process (Market Size -$Billion)

• 8.1 Morphological Process
• 8.2 Physicochemical Process

9. Nano Toxicity and Safety Market- By Toxicity Tests (Market Size -$Billion)

• 9.1 Cell Cultures (In Vitro)
  • 9.1.1 2D Models
  • 9.1.2 3D Models
• 9.2 Living Organisms (In Vivo)
  • 9.2.1 Aquatic Models
  • 9.2.2 Small Rodents (Mammal models)

10. Nano Toxicity and Safety Market- By Nanoparticles (Market Size -$Billion)

• 10.1 Titanium Dioxide Nanoparticles
• 10.2 Silver Nanoparticles
• 10.3 Others

11. Nano Toxicity and Safety Market- By Toxicity (Market Size -$Billion)

• 11.1 Size-dependent Toxicity
• 11.2 Surface-dependent Toxicity
• 11.3 Shape-dependent Toxicity
• 11.4 Aggregation or agglomeration-dependent Toxicity
• 11.5 Dose-dependent Toxicity

12. Nano Toxicity and Safety Market- By Application (Market Size -$Billion)

• 12.1 Energy
• 12.2 Materials and Health
• 12.3 Medical Systems
• 12.4 Agriculture
• 12.5 Pharmaceutic
• 12.6 Cosmetic
• 12.7 Others (Engineering, Food and Others)

13. Nano Toxicity and Safety Market - By Geography (Market Size -$Billion)

• 13.1 North America
  • 13.1.1 U.S.
  • 13.1.2 Canada
  • 13.1.3 Mexico
• 13.2 South America
  • 13.2.1 Brazil
  • 13.2.2 Argentina
  • 13.2.3 Colombia
  • 13.2.4 Rest of South America
• 13.3 Europe
  • 13.3.1 U.K
  • 13.3.2 Germany
  • 13.3.3 Italy
  • 13.3.4 France
  • 13.3.5 Spain
  • 13.3.6 Rest of Europe
• 13.4 Asia Pacific
  • 13.4.1 China
  • 13.4.2 India
  • 13.4.3 Japan
  • 13.4.4 South Korea
  • 13.4.5 Australia & New Zealand
  • 13.4.6 Rest of Asia Pacific

14. Nano Toxicity and Safety Market- Entropy

• 14.1 New Product Launches
• 14.2 M&A's, Collaborations, JVs and Partnerships

15. Nano Toxicity and Safety Market Company Analysis

(Market Share, Company Revenue, Products, M&A, Developments)

• 15.1 Company 1
• 15.2 Company 2
• 15.3 Company 3
• 15.4 Company 4
• 15.5 Company 5
• 15.6 Company 6
• 15.7 Company 7
• 15.8 Company 8
• 15.9 Company 9
• 15.10 Company 10

"*Financials would be provided on a best-efforts basis for private companies"